RECURRENT CERVICAL CARCINOMA
Clinical trials for RECURRENT CERVICAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT CERVICAL CARCINOMA trials appear
Sign up with your email to follow new studies for RECURRENT CERVICAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo tested in fight against advanced cervical cancer
Disease control OngoingThis study is testing whether a combination of two immunotherapy drugs, dostarlimab and cobolimab, can help control advanced cervical cancer that has spread or come back. It will involve about 66 adults whose cancer has progressed after standard platinum-based chemotherapy. The m…
Matched conditions: RECURRENT CERVICAL CARCINOMA
Phase: PHASE2 • Sponsor: Meghan Shea • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Cancer trial matches drugs to your Tumor's DNA
Disease control OngoingThis large national trial is testing whether choosing cancer drugs based on the specific genetic changes found in a patient's tumor is more effective than standard approaches. It is for adults with advanced solid tumors, lymphoma, or multiple myeloma that have progressed after at…
Matched conditions: RECURRENT CERVICAL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
New immune therapy trial offers hope for women with Tough-to-Treat cervical cancer
Disease control OngoingThis study is testing whether the immunotherapy drug nivolumab can help control advanced cervical cancer that has returned or spread after initial treatment. It involves 26 women with persistent or recurrent cervical cancer who have already tried one prior chemotherapy regimen. T…
Matched conditions: RECURRENT CERVICAL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 18, 2026 14:40 UTC
-
Blood test could predict cervical Cancer's return
Knowledge-focused OngoingThis study is testing a new blood test to see if it can find tiny pieces of HPV DNA from cervical cancer in the bloodstream. Researchers want to see if this test can help predict how well treatment is working and detect if the cancer comes back earlier than current methods. The s…
Matched conditions: RECURRENT CERVICAL CARCINOMA
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:35 UTC
-
Can blood tests tame Chemo's painful side effects?
Knowledge-focused TerminatedThis study aims to see if doctors can reliably measure the amount of a common chemotherapy drug (paclitaxel) in a patient's blood. The goal is to learn if tracking these levels can help find the right dose to fight cancer while reducing a severe side effect: nerve damage that cau…
Matched conditions: RECURRENT CERVICAL CARCINOMA
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:39 UTC